GERN news. Small Interfering RNA (siRNA) Conference & Exposition to Take Place April 19-21, 2004 in San Diego, CA
PR Newswire - February 11, 2004 12:00
SAN DIEGO, Feb 11, 2004 /PRNewswire via COMTEX/ -- Small interfering RNAs (siRNAs) have gained much attention from the biotech and pharmaceutical industries in recent years. Due to their powerful ability in selective gene silencing, siRNAs hold great commercial prospects not only as a handy research tool, but also as a new approach for effective therapeutics. The "2nd Annual siRNA in Drug Discovery & Development" conference and exposition, organized by Strategic Research Institute, is scheduled to take place April 19-21, 2004 at the Marriott Del Mar in San Diego, CA. The upcoming conference will feature senior-level management and research scientists from major pharmaceutical and biotech companies as well as siRNA/RNAi therapeutic, reagent, functional genomic, and other RNAi companies.
The conference agenda is divided into the following sections:
- siRNA/RNAi in Target Validation & Therapeutics
- Antisense and Other Oligonucleotide Therapeutics
- In Vivo Monitoring in RNAi, Protein Profiling & Nucleic Acid Delivery
- Intellectual Property Landscape in RNAi
- Strategic Alliances and Partnering Opportunities to Build a Successful
RNAi Business
There will be over 30 different presentations represented by 38 different companies at the upcoming event. Some of the companies participating include Alnylam Pharmaceuticals, Inc., Ambion, Amgen, Archemix, Avocel, Inc., Beckman Research Institute of the City of Hope, Cyntellect, Cytrx Corporation, Dharmacon, Exelixis, Foley & Lardner, Genomics Institute of the Novartis Research Foundation, Geron Corporation, Harvard Medical School, Intradigm, Invitrogen, ISIS Pharmaceuticals, Lawrence Berkeley National Laboratory, Massachusetts Institute of Technology, McDonnell, Boehnen, Hulbert & Berghoff, Nucleonics, Inc., Pierce Biotechnology, Promega, Rosetta Inpharmatics, Sirna Therapeutics, University of California San Diego, Xenogen, Zygogen and many more.
To request a copy of the agenda and schedule in PDF format, please contact Glenn Pascual at gpascual@srinstitute.com or call 212.967.0095, ext. 245. and include name, title, company and mailing address.
To register as an exhibitor or inquire about sponsorship opportunities, please contact Kellie Swanstrom at kswanstrom@srinstitute.com
Current Sponsors and Exhibitors signed up currently include Sirna Therapeutics, Xenogen Corporation, Archemix, Ambion, Promega, Proligo, and Dharmacon.
To inquire on how to become a media partner, please contact Cheryl Kahan- Radhuber at ckahan-radhuber@srinstitute.com
SOURCE Strategic Research Institute
